PET imaging of brain macrophages using the peripheral benzodiazepine receptor in a macaque model of neuroAIDS

Journal of Clinical Investigation

Volumn 113, Issue 7, 2004, Pages 981-989

  Venneti, Sriram ^a   Lopresti, Brian J ^a   Wang, Guoji ^a   Bissel, Stephanie J ^b   Mathis, Chester A ^a   Meltzer, Carolyn C ^a   Boada, Fernando ^a   Capuano III, Saverio ^a   Kress, Geraldine J ^a   Davis, Denise K ^a   Ruszkiewicz, James ^a   Reynolds, Ian J ^a   Murphey Corb, Michael ^a   Trichel, Anita M ^a   Wisniewski, Stephen R ^c   Wiley, Clayton A ^a,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR; CARBON 11; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; AUTOPSY; BRAIN TISSUE; CONTROLLED STUDY; ENANTIOMER; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHESIS; IN VIVO STUDY; ISOTOPE LABELING; MACACA; MACROPHAGE; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ENCEPHALITIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; MACACA; MACROPHAGES; MAGNETIC RESONANCE IMAGING; RECEPTORS, GABA-A; SIMIAN IMMUNODEFICIENCY VIRUS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 11144355966     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200420227     Document Type: Article

References (53)

1. Dore, G.J., et al. 1999. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS. 13:1249-1253.
2. Brew, B.J. 1999. AIDS dementia complex. Neurol. Clin. 17:861-881.
3. Cinque, P., Scarpellini, P., Vago, L., Linde, A., and Lazzarin, A. 1997. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS. 11:1-17.
4. McArthur, J.C. 1997. NeuroAIDS: diagnosis and management. Hosp. Prac. (Off. Ed.) 32:73-74, 77-79, 84, passim.
5. Price, R.W., et al. 1999. Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team. AIDS. 13:1677-1685.
6. Baskin, G.B., Murphey-Corb, M., Roberts, E.D., Didier, P.J., and Martin, L.N. 1992. Correlates of SIV encephalitis in rhesus monkeys. J. Med. Primatol. 21:59-63.
7. Budka, H. 1991. Neuropathology of human immunodeficiency virus infection. Brain Pathol. 1:163-175.
8. Lackner, A.A., et al. 1991. Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys. Am J. Pathol. 139:609-621.
9. Kaul, M., Garden, G.A., and Lipton, S.A. 2001. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature. 410:988-994.
10. Post, M.J., et al. 1988. CT, MR, and pathology in HIV encephalitis and meningitis. AJR Am. J. Roentgenol 151:373-380.
11. Avison, M.J., Nath, A., and Berger, J.R. 2002. Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance? Trends Neurosci. 25:468-473.
12. Paul, R., Cohen, R., Navia, B., and Tashima, K. 2002. Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1. Neurosci. Biobehav. Rev. 26:353-359.
13. McArthur, J.C., et al. 1990. Incidental white matter hyperintensities on magnetic resonance imaging in HIV-1 infection. Multicenter AIDS Cohort Study. J. Acquir. Immune Defic. Syndr. 3:252-259.
14. Sonnerborg, A., et al. 1990. Quantitative detection of brain aberrations in human immunodeficiency virus type 1-infected individuals by magnetic resonance imaging. J. Infect. Dis. 162:1245-1251.
15. Post, M.J., et al. 1992. Sequential cranial MR findings of asymptomatic and neurologically symptomatic HIV+ subjects. AJNR Am. J. Neuroradiol. 13:359-370.
16. Raininko, R., et al. 1992. Radiological study of the brain at various stages of human immunodeficiency virus infection: early development of brain atrophy. Neuroradiology. 34:190-196.
17. Aylward, E.H., et al. 1993. Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology. 43:2099-2104.
18. Wenserski, F., von Giesen, H.J., Witrsack, H.J., Aulich, A., and Arendt, G. 2003. Human immunodeficiency virus 1-associated minor motor disorders: perfusion-weighted MR imaging and H MR spectroscopy. Radiology. 228:185-192.
19. Pascal, S., et al. 1991. Metabolic asymmetries in asymptomatic HIV-1 seropositive subjects: relationship to disease onset and MRI findings. J. Nucl. Med. 32:1725-1729.
20. Rosci, M.A., et al. 1992. Methods for detecting early signs of AIDS dementia complex in asymptomatic HIV-1-infected subjects. AIDS. 6:1309-1316.
21. Chang, L., Ernst, T., Leonido-Yee, M., Walot, I., and Singer, E. 1999. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology. 52:100-108.
22. Chang, L., et al. 2001. Neural correlates of attention and working memory deficits in HIV patients. Neurology. 57.1001-1007.
23. Ernst, T., Chang, L., and Arnold, S. 2003. Increased glial metabolites predict increased working memory network activation in HIV brain injury. Neuroimage. 19:1686-1693.
24. Banati, R.B. 2002. Visualising microglial activation in vivo. Glia. 40:206-217.
25. Cagnin, A., Gerhard, A., and Banati, R.B. 2002. In vivo imaging of neuroinflammation. Eur. Neuropsychopharmacol. 12:581-586.
26. Vowinckel, E., et al. 1997. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Neurosci. Res. 50:345-353.
27. Banati, R.B., et al. 2000. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain. 123:2321-2337.
28. Stephenson, D.T., et al. 1995. Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J. Neurosci. 15:5263-5274.
29. Raghavendra Rao, V.L., Dogan, A., Bowen, K.K., and Dempsey, R.J. 2000. Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus. Exp. Neurol. 161:102-114.
30. Debruyne, J.C., et al. 2003. PET visualization of microglia in multiple sclerosis patients using [11C]PK11195. Eur. J. Neurol. 10:257-264.
31. Banati, R.B., et al. 1999. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology. 53:2199-2203.
32. Cagnin, A., et al. 2001. In vivo visualization of activated glia by [11C](R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain. 124:2014-2027.
33. Cagnin, A., et al. 2001. In-vivo measurement of activated microglia in dementia. Lancet. 358:461-467.
34. Gerhard, A., et al. 2003. [(11)C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology. 61:686-689.
35. Schmitz, J.E., et al. 1999. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 283:857-860.
36. Shah, F., Hume, S.P., Pike, V.W., Ashworth, S., and McDermott, J. 1994. Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. Nucl. Med. Biol. 21:573-581.
37. Cleij, M.C., Aigbirhio, F.I., Baron, J.C., and Clark, J.C. 2003. Base-promoted dechlorination of (R)[C-11]PK-11195. International Symposium on Radiopharmaceutical Chemistry, 15th. Sydney, Australia. 46(Suppl.1):588.
38. Woods, R.P., Cherry, S.R., and Mazziotta, J.C. 1992. Rapid automated algorithm for aligning and reslicing PET images. J. Comput. Assist. Tomogr. 16:620-633.
39. Logan, J., et al. 1996. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 16:834-840.
40. Johnson, L.A., Pearlman, J.D., Miller, C.A., Young, T.I., and Thulborn, K.R. 1993. MR quantification of cerebral ventricular volume using a semiautomated algorithm. AJNR Am. J. Neuroradiol. 14:1373-1378.
41. Joe, B.N., et al. 1999. Brain tumor volume measurement: comparison of manual and semiautomated methods. Radiology. 212:811-816.
42. Bissel, S.J., et al. 2002. Macrophages relate presynaptic and postsynaptic damage in simian immunodeficiency virus encephalitis. Am. J. Pathol. 160:927-941.
43. Jordan-Sciutto, K.L., Wang, G., Murphey-Corb, M., and Wiley, C.A. 2002. Cell cycle proteins exhibit altered expression patterns in lentiviral-associated encephalitis. J. Neurosci. 22:2185-2195.
44. Casellas, P., Galiegue, S., and Basile, A.S. 2002. Peripheral benzodiazepine receptors and mitochondrial function. Neurochem. Int. 40:475-486.
45. Jayakumar, A.R., Panickar, K.S., and Norenberg, M.D. 2002. Effects on free radical generation by ligands of the peripheral benzodiazepine receptor in cultured neural cells. J. Neurochem. 83:1226-1234.
46. Williams, K.C., and Hickey, W.F. 2002. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu. Rev. Neurosci. 25:537-562.
47. Gunn, R.N., et al. 1998. Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET. Neuroimage. 8:426-440.
48. Lammertsma, A.A., and Hume, S.P. 1996. Simplified reference tissue model for PET receptor studies. Neuroimage. 4:153-158.
49. Gunn, R.N., Lammertsma, A.A., Hume, S.P., and Cunningham, V.J. 1997. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage. 6:279-287.
50. Lockhart, A., et al 2003. The peripheral benzodiazepine receptor ligand PK11195 binds with high affinity to the acute phase reactant α1-acid glycoprotein: implications for the use of the ligand as a CNS inflammatory marker(1). Nucl. Med. Biol. 30:199-206.
51. Mankowski, J.L., Queen, S.E., Tarwater, P.J., Adams, R.J., and Guilarte, T.R. 2003. Elevated peripheral benzodiazepine receptor expression in simian immunodeficiency virus encephalitis. J. Neuroenvirol. 9:94-100.
52. Glass, J.D., Fedor, H., Wesselingh, S.L., and McArthur, J.C. 1995. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38:755-762.
53. Jack, C.R., Jr., et al. 2003. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology. 60:253-260.